HC Wainwright & Co. : Pyxis Oncology (PYXS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $7.00.
Zhitong FinanceApr 10 18:11
Pyxis Oncology Analyst Ratings
BenzingaApr 10 18:08
HC Wainwright & Co. Reiterates Buy on Pyxis Oncology, Maintains $7 Price Target
BenzingaApr 10 18:09
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Spectral AI (MDAI) and Pyxis Oncology (PYXS)
TipRanksMar 28 18:40
Optimistic Buy Rating for Pyxis Oncology's PYX-201 Based on Strong Safety Profile and Promising Therapeutic Potential
TipRanksMar 25 09:26
Pyxis Oncology (PYXS) Gets a Buy From RBC Capital
TipRanksMar 22 18:38
Buy Rating on Pyxis Oncology: Promising PYX-201's Safety Profile and Strategic Focus on Solid Tumors
TipRanksMar 22 18:16
Pyxis Oncology Analyst Ratings
BenzingaMar 22 18:14
Pyxis Oncology (PYXS) Receives a Buy From Leerink Partners
TipRanksMar 19 13:38
Pyxis Oncology Analyst Ratings
BenzingaFeb 9 20:24
Buy Rating for Pyxis Oncology: Advancing ADC Innovation and Immuno-Oncology Pipeline
TipRanksFeb 9 19:15
Pyxis Oncology Analyst Ratings
BenzingaJan 23 22:48
Pyxis Oncology Analyst Ratings
BenzingaNov 30, 2023 19:29
RBC Capital Reaffirms Their Buy Rating on Pyxis Oncology (PYXS)
TipRanksNov 11, 2023 09:49
LifeSci Capital Reaffirms Their Buy Rating on Pyxis Oncology (PYXS)
TipRanksNov 8, 2023 21:58
RBC Capital Initiates Coverage On Pyxis Oncology With Outperform Rating, Announces Price Target of $7
BenzingaSep 5, 2023 19:04
Pyxis Oncology Analyst Ratings
BenzingaSep 5, 2023 19:03
Pyxis Oncology (PYXS) Gets a Buy From LifeSci Capital
TipRanksAug 12, 2023 03:25
Pyxis Oncology Analyst Ratings
BenzingaJul 31, 2023 19:28
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS) and Thermo Fisher (TMO)
TipRanksMay 25, 2023 17:30
No Data
No Data